BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10755402)

  • 1. Limitations of CD44v6 amplification for the detection of tumour cells in the blood of colorectal cancer patients.
    Masson D; Denis MG; Lustenberger P
    Br J Cancer; 2000 Apr; 82(7):1283-9. PubMed ID: 10755402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating tumour cells and nodal metastasis by reverse transcriptase-polymerase chain reaction technique.
    Wong LS; Cantrill JE; Odogwu S; Morris AG; Fraser IA
    Br J Surg; 1997 Jun; 84(6):834-9. PubMed ID: 9189103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients.
    Bustin SA; Gyselman VG; Siddiqi S; Dorudi S
    Int J Surg Investig; 2000; 2(1):49-57. PubMed ID: 12774338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.
    Iinuma H; Okinaga K; Egami H; Mimori K; Hayashi N; Nishida K; Adachi M; Mori M; Sasako M
    Int J Oncol; 2006 Feb; 28(2):297-306. PubMed ID: 16391782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes.
    Bernini A; Spencer M; Frizelle S; Madoff RD; Willmott LD; McCormick SR; Niehans GA; Ho SB; Kratzke RA
    Cancer Detect Prev; 2000; 24(1):72-9. PubMed ID: 10757125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD44 and CD44v6 serum levels in patients with colorectal cancer are independent of tumor stage and tissue expression of CD44v6.
    Weg-Remers S; Hildebrandt U; Feifel G; Moser C; Zeitz M; Stallmach A
    Am J Gastroenterol; 1998 May; 93(5):790-4. PubMed ID: 9625129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples.
    Wharton RQ; Jonas SK; Glover C; Khan ZA; Klokouzas A; Quinn H; Henry M; Allen-Mersh TG
    Clin Cancer Res; 1999 Dec; 5(12):4158-63. PubMed ID: 10632355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of tumor cells in peritoneal lavages from patients with gastrointestinal cancer by multiplex reverse transcriptase PCR.
    Schmidt P; Thiele M; Rudroff C; Vaz A; Schilli M; Friedrich K; Scheele J
    Hepatogastroenterology; 2001; 48(42):1675-9. PubMed ID: 11813599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic gene member 2 mRNA expression as a marker to detect circulating enterocytes in the blood of colorectal cancer patients.
    Douard R; Le Maire V; Wind P; Sales JP; Dumas F; Fayemendi L; Landi B; Benichou J; Cugnenc PH; Gayral F; Loric S
    Surgery; 2001 May; 129(5):587-94. PubMed ID: 11331451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells.
    Hampton R; Walker M; Marshall J; Juhl H
    Oncogene; 2002 Nov; 21(51):7817-23. PubMed ID: 12420218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD44v6 has no prognostic value in patients with colorectal cancer.
    Jüngling B; Menges M; Goebel R; Wittig BM; Weg-Remers S; Pistorius G; Schilling M; Bauer M; König J; Zeitz M; Stallmach A
    Z Gastroenterol; 2002 Apr; 40(4):229-33. PubMed ID: 11961731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS.
    Martin VM; Siewert C; Scharl A; Harms T; Heinze R; Ohl S; Radbruch A; Miltenyi S; Schmitz J
    Exp Hematol; 1998 Mar; 26(3):252-64. PubMed ID: 9502622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of disseminated tumour cells as a potential surrogate-marker for monitoring palliative chemotherapy in colorectal cancer patients.
    Staritz P; Kienle P; Koch M; Benner A; von Knebel Doeberitz M; Rudi J; Weitz J
    J Exp Clin Cancer Res; 2004 Dec; 23(4):633-9. PubMed ID: 15743034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
    Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
    Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
    Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
    Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
    Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
    Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
    Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
    Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of circulating tumor cells by cytokeratin 20 and prostate stem cell antigen RT-PCR in blood of patients with gastrointestinal cancers.
    Lukyanchuk VV; Friess H; Kleeff J; Osinsky SP; Ayuni E; Candinas D; Roggo A
    Anticancer Res; 2003; 23(3B):2711-6. PubMed ID: 12894563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.